《睡眠專業人士雜誌》
星期四, 七月 23, 2026
ResMed announced that it has entered into a definitive agreement to acquire Noctrix Health, a medical technology company focused on treating restless legs syndrome (RLS). The acquisition marks a strategic expansion of ResMed’s portfolio into adjacent neurological sleep disorders, reinforcing its mission to improve patient outcomes and quality of life. […]
Eli Lilly and Company and Centessa Pharmaceuticals plc, a clinical-stage company developing a new class of medicines for the treatment of excessive daytime sleepiness and other neurological conditions, announced a definitive agreement for Lilly to acquire Centessa. Centessa is advancing a pipeline of orexin receptor 2 (OX2R) agonists designed to […]
Resmed announced it has acquired VirtuOx, a leading independent diagnostic testing facility (IDTF) for sleep, respiratory, and cardiac conditions. The acquisition reflects Resmed’s commitment to improving the way care is delivered by making it more accessible, coordinated, and patient-friendly. With VirtuOx’s at-home diagnostic services, Resmed will be better positioned to […]
Beacon Biosignals announced that it has acquired Cleveland Medical Devices Inc. (known as CleveMed), a leader in home sleep testing (HST) technology and services, in a strategic transaction that will strengthen both companies’ capabilities. Jacob Donoghue, MD, PhD, CEO and co-founder of Beacon Biosignals, commented, “There is a lot we […]
Persante Health Care has acquired Sleep Management Services (SMS), a business process outsourcing company specializing in sleep care services across Arkansas and Texas. Funding for the acquisition was provided by Peninsula Capital Partners, a Detroit-based private investment firm that has raised and invested over $2 billion in capital across eight […]
EnsoData announces the acquisition of sleep testing diagnostic technology from Resonea aimed at reducing the cost of systematically addressing sleep apnea across large patient populations. With this acquisition, EnsoData adds acoustic flow and microphone data channels to enable an exciting new way to pre-screen patients for sleep apnea with an […]
ResMed today announced the acquisition of privately held Somnoware, a U.S. leader in sleep and respiratory care diagnostics software. Somnoware software streamlines the processes of physicians as well as sleep and pulmonary function testing labs for diagnosing and evaluating a patient’s sleep and respiratory care test results, ordering PAP treatment […]
Nox Health announced that it has closed the acquisition of Somryst, the first and only FDA-approved prescription digital therapeutic that delivers effective, first-line treatment for adults with chronic insomnia. The addition of Somryst expands Nox Health’s comprehensive suite of tools and programs that address a critical and growing demand for sleep […]
Nox Health has acquired Somryst, the first FDA-cleared Prescription Digital Therapeutic (PDT) that delivers effective, first-line treatment for adults with chronic insomnia. This acquisition deepens the Nox value-based healthcare programs, as it seeks to reframe sleep as a critical and powerful intervention strategy for chronic health conditions management. “The acquisition […]
A new book, Transform Dental Sleep, from dental sleep medicine industry insider Jason Tierney aims to help dentists grow their sleep practices. Over 30,000,000 Americans suffer from obstructive sleep apnea. An unprecedented PAP recall has left millions of people without treatment. 10,000 dentists attended a dental sleep medicine course last year. Less […]
